首页> 美国卫生研究院文献>Scientific Reports >Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai China
【2h】

Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai China

机译:传播是上海地区治疗结核病患者耐药的一个明显原因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is generally believed that drug resistance among treated tuberculosis (TB) patients is as a result of acquired drug resistance due to inappropriate treatment. Previous studies have shown that primary drug resistance caused by transmission also plays a role among treated cases. Differentiating the two types of drug resistance will help in developing appropriate strategies for control of drug resistant tuberculosis. In this study, we tested the hypothesis that drug resistance among treated TB patients is mainly caused by primary resistance rather than acquired resistance. Defining resistance profiles by molecular drug susceptibility test, we used Unit Variable Number Tandem Repeats (VNTR) to genotype and Whole Genome Sequencing (WGS) to confirm the accordance of the first and last Mycobacterium tuberculosis isolates from treated pulmonary TB patients in Shanghai from 2009–2015. Among 81 patients with increasing drug resistance, out of 390 patients enrolled, paired isolates from 59.3% (48/81) had different VNTR patterns indicating primary drug resistance. Our results have demonstrated that primary resistance due to exogenous reinfection is the major cause of drug resistance among treated TB patients in Shanghai; thus, strategies aimed at preventing and interrupting transmission are urgently needed to effectively reduce the epidemic of drug resistant tuberculosis.
机译:通常认为,治疗的结核病(TB)患者中的耐药性是由于治疗不当而获得的耐药性的结果。先前的研究表明,由传播引起的原发性耐药性在治疗病例中也起作用。区分两种类型的耐药性将有助于制定控制耐药性结核病的适当策略。在这项研究中,我们检验了以下假设:治疗的结核病患者中的耐药性主要是由原发性耐药而不是获得性耐药引起的。通过分子药物敏感性试验确定耐药性,我们使用单位可变数目串联重复序列(VNTR)进行基因型和全基因组测序(WGS),以确认2009-2009年在上海治疗的肺结核分枝杆菌的第一株和最后一株结核分枝杆菌的分离情况。 2015年。在81例耐药性增加的患者中,纳入的390例患者中,来自59.3%(48/81)的配对分离株具有不同的VNTR模式,表明原发性耐药。我们的结果表明,外源性再感染引起的原发性耐药是上海治疗结核病患者耐药的主要原因。因此,迫切需要旨在预防和阻断传播的策略,以有效减少耐药性结核病的流行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号